Piperidinyl-3-(aryloxy)propanamides and propanoates
US11045457B2 · kind B2 · utility
3Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2019 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Feb 28, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula 1, stereoisomers thereof, and pharmaceutically acceptable salts thereof, wherein L, r, s, R5, R6, R7, R9, R10, R11, R12, X1, X2, X3, X4, X13, and X14 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating diseases, disorders, and conditions associated with SSTR4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.